|
|
| Line 13: |
Line 13: |
| <span style="display:none">Spleen</span> | | <span style="display:none">Spleen</span> |
| <span style="display:none">Leukemia</span> | | <span style="display:none">Leukemia</span> |
| | <span style="display:none">isPatientAssociation</span> |
| <span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | | <span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> |
| <span style="display:none">isPatientAssociation</span>
| |
| <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> |
| <span style="display:none">hasCancerType::C00-C97: All cancer types</span> | | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> |
| <span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span>
| |
| <span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span>
| |
| <span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span>
| |
| <span style="display:none">hasCancerType::C40-C41: Bone cancers</span>
| |
| <span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span>
| |
| <span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span>
| |
| <span style="display:none">hasCancerType::C50: Breast cancer</span>
| |
| <span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span>
| |
| <span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>
| |
| <span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span>
| |
| <span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span>
| |
| <span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span>
| |
| <span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span>
| |
| <span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>
| |
| <span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span>
| |
| <span style="display:none">hasCancerType::D10-D36: Benign tumour</span>
| |
| <span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>
| |
| <span style="display:none">hasCancerType::unknown</span>
| |
forpatients denmarkcountry
Go back to Denmark page
Primary purpose: To raise awareness of multiple myeloma and AL amyloidosis, advocate for patients and their relatives to secure optimal treatment options, organize activities and support networks, and facilitate the exchange of experiences among patients and their relatives.
Cancer areas of interest: C81-C96: Cancers of the blood and immune system.
Access to information: Click here to access.
Blood
Bone marrow
Lymph nodes
Spleen
Leukemia
isPatientAssociation
hasCancerType::C81-C96: Cancers of the blood and immune system
hasCancerType::C00-D48: All neoplasms
hasCancerType::C00-C97: All cancer types
